Gain Access to exclusive preclinical content.
Complete the form below to gain access to mattis aliquet nunc aliquam tempor. We’ll assign a user name and password, then send you a link. Thanks!

Get Access Register

EXCLUSIVE PRECLINICAL CONTENT.
You must log in to access content on this page. Or click here to request access.
VEGFR3 tyrosine kinase inhibition aggravates cisplatin nephrotoxicity

Laurence M Black, Elisa R Farrell, Daria Barwinska, Gunars Osis, Anna A Zmijewska, Amie M. Traylor, Stephanie K Esman, Subhashini Bolisetty, Grace Whipple, Malgorzata M. Kamocka, Seth Winfree, Daryll R Spangler, Shehnaz Khan, Abolfazl Zarjou, Tarek M. El-Achkar, and Anupam Agarwal, "VEGFR3 tyrosine kinase inhibition aggravates cisplatin nephrotoxicity", American Journal of Physiology, Renal Physiology, 18 OCT 2021, https://doi.org/10.1152/ajprenal.00186.2021.